Susan Morrison - 15 May 2025 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP & Chief Admin. Officer
Signature
/s/ Rachel Malina, Attorney-in-Fact for Susan M. Morrison
Issuer symbol
TNDM
Transactions as of
15 May 2025
Net transactions value
-$21,149
Form type
4
Filing time
19 May 2025, 18:06:41 UTC
Previous filing
27 Feb 2025
Next filing
05 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morrison Susan EVP & Chief Admin. Officer 12400 HIGH BLUFF DRIVE, SAN DIEGO /s/ Rachel Malina, Attorney-in-Fact for Susan M. Morrison 19 May 2025 0001582970

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Award $21,255 +1,359 +4.4% $15.64 32,548 15 May 2025 Direct F1
transaction TNDM Common Stock Options Exercise $0 +162 +0.5% $0.000000 32,710 15 May 2025 Direct
transaction TNDM Common Stock Tax liability $1,067 -47 -0.14% $22.70 32,663 15 May 2025 Direct F2
transaction TNDM Common Stock Options Exercise $0 +474 +1.5% $0.000000 33,137 15 May 2025 Direct
transaction TNDM Common Stock Tax liability $3,087 -136 -0.41% $22.70 33,001 15 May 2025 Direct F2
transaction TNDM Common Stock Options Exercise $0 +1,503 +4.6% $0.000000 34,504 15 May 2025 Direct
transaction TNDM Common Stock Tax liability $9,761 -430 -1.2% $22.70 34,074 15 May 2025 Direct F2
transaction TNDM Common Stock Options Exercise $0 +4,387 +13% $0.000000 38,461 15 May 2025 Direct
transaction TNDM Common Stock Tax liability $28,488 -1,255 -3.3% $22.70 37,206 15 May 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -162 -100% $0.000000 0 15 May 2025 Common Stock 162 Direct F3, F4, F5
transaction TNDM Restricted Stock Unit Options Exercise $0 -474 -100% $0.000000 0 15 May 2025 Common Stock 474 Direct F4, F6, F7
transaction TNDM Restricted Stock Unit Options Exercise $0 -1,503 -20% $0.000000 6,012 15 May 2025 Common Stock 1,503 Direct F8, F9, F10
transaction TNDM Restricted Stock Unit Options Exercise $0 -4,387 -33% $0.000000 8,774 15 May 2025 Common Stock 4,387 Direct F9, F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2024, through May 15, 2025. This transaction is also exempt under Rule 16b-3(c).
F2 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F3 Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F4 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F5 RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
F6 Awarded on May 25, 2022 pursuant to the 2013 Plan.
F7 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
F8 Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F9 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F10 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
F11 Awarded on May 23, 2024 pursuant to the 2023 Plan.
F12 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.